Evnin Luke's Form 4 filing
Werewolf Therapeutics, Inc. (HOWL) · filed Jan 12, 2026
- Accession no.
- 0001134657-26-000004
- Filed
- Jan 12, 2026
- Trade date
- Jan 8-12, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $53.5K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Evnin LukeCIK 0001134657 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 8, 2026 | Common Stock | SSaleDisposed | −7,716 | $0.63 | −$4,861.08 | 2,393,527 | Indirect | |
| Jan 9, 2026 | Common Stock | SSaleDisposed | −24,678 | $0.61 | −$15,053.58 | 2,368,849 | Indirect | |
| Jan 12, 2026 | Common Stock | SSaleDisposed | −58,980 | $0.57 | −$33,618.6 | 2,309,869 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.